13F filer · CIK 1825034
Euclidean Capital LLC
NEW YORK, NY · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$439.8M
+$47.5M vs prior
Positions
11
New / sold out
1 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $9.0M · sells $0
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | TEAMSHARES INC | +1,099,974 | – | +$9.0M |
Biggest sells vs Q1 2026
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | VANGUARD INTL EQUITY INDEX FALLWRLD EX US | 3,243,484 | $271.6M | 61.76% |
| 2 | VANGUARD INDEX FDSVALUE ETF | 520,000 | $113.3M | 25.76% |
| 3 | ISHARES TRMSCI INDIA ETF | 369,600 | $18.3M | 4.15% |
| 4 | ORIC PHARMACEUTICALS INCCOM | 989,410 | $10.7M | 2.44% |
| 5 | TEAMSHARES INCCOM | 1,099,974 | $9.0M | 2.06% |
| 6 | FOGHORN THERAPEUTICS INCCOM | 1,573,761 | $7.7M | 1.75% |
| 7 | PMV PHARMACEUTICALS INCCOM | 2,627,643 | $3.5M | 0.80% |
| 8 | ALECTOR INCCOM | 1,307,858 | $2.6M | 0.60% |
| 9 | SURROZEN INCCOM NEW | 87,696 | $2.3M | 0.52% |
| 10 | TENAYA THERAPEUTICS INCCOM | 1,015,705 | $750.7K | 0.17% |
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.